Ragulan, Chanthirika
Eason, Katherine http://orcid.org/0000-0001-6903-9067
Fontana, Elisa
Nyamundanda, Gift
Tarazona, Noelia
Patil, Yatish
Poudel, Pawan
Lawlor, Rita T.
Del Rio, Maguy
Koo, Si-Lin
Tan, Wah-Siew
Sclafani, Francesco
Begum, Ruwaida
Teixeira Mendes, Larissa S.
Martineau, Pierre
Scarpa, Aldo http://orcid.org/0000-0003-1678-739X
Cervantes, Andrés http://orcid.org/0000-0003-3806-3691
Tan, Iain Beehuat http://orcid.org/0000-0003-4951-0354
Cunningham, David
Sadanandam, Anguraj
Article History
Received: 24 January 2019
Accepted: 23 April 2019
First Online: 21 May 2019
Competing Interests
: A.Sa. has ownership interest as a patent inventor for a patent entitled “Colorectal cancer classification with differential prognosis and personalized therapeutic responses” (patent number PCT/IB2013/060416). A.Sa. receives research funding from Bristol-Myers Squibb Merck KGaA and Pierre Fabre. D.C. receives research funding from – Amgen, Sanofi, Merrimack, AstraZeneca, Celgene, MedImmune, Bayer, 4SC, Clovis, Eli Lilly, Janssen, and Merck. The remaining authors declare no competing interests.